One Health float on AIM
March 2025
One Health Group PLC provides medical services, in the form of elective surgical care, to support the NHS in the management of patients, through a growing network of community-based outreach clinics and independent hospitals.
The Company was incorporated in 2001, and its existing business was established in 2004 by Derek Bickerstaff, a practising consultant surgeon, in response to Government legislation, specifically the Patient Choice initiative.
One Health has Any Qualified Provider status and provides quality elective care to increasing numbers of NHS patients, through an extensive network of supply partners, which is a proven method for managing and reducing NHS waiting lists.
One Health forms a fundamental part of the local supply chain to several NHS commissioners, across the North of England.
The Company was admitted to trading on the Aquis Exchange in November 2022.
Admission to trading on AIM
On 20th March 2025, the Company announced its admission to trading on AIM by way of a Conditional Placing of 4,083,609 Ordinary Shares at the issue price of 180 pence per Ordinary Share. An Open Offer of up to 277,634 new Ordinary Shares at the Issue Price. A Retail Offer of up to 277,777 new Ordinary Shares at the Issue Price and the Cancellation of Admission to trading on the AQSE Growth Market.
The aggregate gross proceeds from the Capital Raising were approximately £7.4 million.
The Perivan shareholder communications team was delighted to work with Panmure Liberum who acted as AQSE Corporate Adviser and Broker and Nominated Adviser for the purposes of Admission to trading on AIM on successful production and publication of the 75 page admission document.
Perivan is the market leader for IPO admission document production and specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies, private companies, and open and closed-ended funds.
